Advertisement
Screener

OptimizeRx Corporation (OPRX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value

3.1 / 5 stars · 53/86 Roast Me

OptimizeRx Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value

OptimizeRx Corporation (OPRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value of $11.52 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue · last filed 2026-03-12

  • OptimizeRx Corporation share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2025 was $11.52, a 47.16% decline from fiscal 2024.
  • OptimizeRx Corporation share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2024 was $21.80.
  • OptimizeRx Corporation share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2022 was $52.07, a 111.93% increase from fiscal 2021.
  • OptimizeRx Corporation share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2021 was $24.57.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 12 month as first filed
2025-12-31$11.52
10-K · filed 2026-03-12
2024-12-31$21.80
10-K · filed 2025-03-20
2022-12-31$52.07
10-K · filed 2024-04-15
$37.83
10-K · filed 2023-03-10
2021-12-31$24.57
10-K/A · filed 2023-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
TEN Holdings, Inc. (XHLD)United States$0.152B
Future FinTech Group Inc. (FTFT)$0.144B
Datavault AI Inc. (DVLT)United States$0.144B-1.77
RESOURCES CONNECTION, INC. (RGP)United States$0.129B-3.84
DHI GROUP, INC. (DHX)United States$0.205B132.15
COMSCORE, INC. (SCOR)United States$0.073B-6.35
Research Solutions, Inc. (RSSS)United States$0.071B27.67
Getty Images Holdings, Inc. (GETY)United States$0.068B-2.33
FiscalNote Holdings, Inc. (NOTE)United States$0.065B
Bridger Aerospace Group Holdings, Inc. (BAER)United States$0.049B-9.14